Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Player Avatar rqtect (< 20) Submitted: 4/5/2012 1:45:36 PM : Outperform Start Price: $1.57 KERX Score: +10.98

way oversold

Featured Broker Partners


Advertisement